NPPA issued the ceiling price of the Darunavir (A) +Ritonavir (B) and other formulations

Mar 01, 2024 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on February 28, 2024, issued the ceiling price of the Darunavir (A) +Ritonavir (B) and other formulations exclusive of Goods and Services Tax applicable, if any, in respect of the Scheduled formulation with the dosage form & strength and unit specified in the Table. 

Kindly find the table attached to the document below.

[Notification No. S. O. 939(E)]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT